REVIEW OF: Hokelekli FO et al, J Child Adolesc Psychopharmacol 2025;35(8):463–470
STUDY TYPE: Psychometric validation study (observational cohort)

Side effects are one of the main reasons kids stop antidepressants, yet most monitoring tools take too long for routine visits. Could a three-question scale give clinicians a quick, reliable snapshot of how much medication side effects are actually bothering their patients?

Researchers analyzed data from 746 youth ages 8–20 in the Texas Youth Depression and Suicide Research Network who were taking antidepressants. Participants completed the Frequency, Intensity, Burden of Side Effects Rating—Child (FIBSER-C), a brief self-report tool with three questions: How often do side effects happen? How bad are they? How much do they get in the way of daily life? Each item is scored 0–3, for a total of 0–9.

The three questions held together well statistically and functioned as a single measure of side effect burden. About one-third of youth reported symptoms at least some of the time, 14% said symptoms were “bad” or worse, and about one-quarter said side effects interfered with daily activities. Reassuringly, higher FIBSER-C scores correlated only weakly with depression severity—suggesting the scale captures medication burden rather than just how depressed a patient feels.

CARLAT TAKE
This is exactly the kind of tool that fits real-world practice. The FIBSER-C takes under a minute, requires no clinician training, and can be completed by the patient in the waiting room. Each item uses plain-language response options (“not at all” to “nearly all of the time”), making it accessible even for younger adolescents. If you treat youth on antidepressants, consider adding it to your intake packet or between-visit check-ins. It’s a natural conversation starter about specific side effects, tolerability, and adherence, which is where medication management often breaks down.